The Glasgow Aneurysm Score (GAS), developed and published by the same
authors, is a clinical prognostic scoring system that predicts mortali
ty when operating on either intact or ruptured abdominal aortic aneury
sms (AAA) taking into account these clinical criteria: patient's age,
shock at presentation, myocardial disease, cerebrovascular disease and
renal disease. The GAS was prospectively evaluated by studying 320 co
nsecutive patients with AAA who were operated on at Glasgow, Aberdeen
and Inverness, Scotland, in the period between January 1990 and May 19
93. Logistic regression analysis showed very similar results to the or
iginal analysis used in developing the score. Age, shock, myocardial d
isease and renal disease were highly significant. Although it was not
significant, cerebrovascular disease weight was not significantly diff
erent to its value in the original analysis. The mortality correlated
well with the values of the score and ranged from 0% for scores below
'70 GAS' to 80% for scores over '95 GAS'. The GAS appears, therefore,
to be a reliable clinical predicative tool in foretelling the outcome
of operating on AAA in terms of operative in-hospital mortality.